Author： Engel Ryan H. Kaklamani Virginia G.
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.67, Iss.9, 2007-01, pp. : 1329-1341
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Overcoming Treatment Resistance in HER2-Positive Breast Cancer: Potential Strategies
By Puglisi Fabio >
Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. :
Access to resources
Recommend
Pertuzumab: In the First-Line Treatment of HER2-Positive Metastatic Breast Cancer
Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. :
By Hare Jennifer I. Moase Elaine H. Allen Theresa M.
Journal of Drug Targeting, Vol. 21, Iss. 1, 2013-01 ,pp. :
By Essers Brigitte A.B. Seferina Shanley C. Tjan-Heijnen Vivianne C.G. Severens Johan L. Novák Annoesjka Pompen Marjolein Oron Ulrich H. Joore Manuela A.
Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. :
By Montemurro Filippo Rossi Valentina Geuna Elena Valabrega Giorgio Martinello Rossella Milani Andrea Aglietta Massimo
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. :